| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3976550
Max Phase: Preclinical
Molecular Formula: C11H17FN4O6S
Molecular Weight: 352.34
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NCC1(F)CNC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O
Standard InChI: InChI=1S/C11H17FN4O6S/c12-11(4-13-5-11)6-14-9(17)8-2-1-7-3-15(8)10(18)16(7)22-23(19,20)21/h7-8,13H,1-6H2,(H,14,17)(H,19,20,21)/t7-,8+/m1/s1
Standard InChI Key: VSSMELCXJUVNNA-SFYZADRCSA-N
Associated Targets(non-human)
KPC-2 Beta-lactamase (208 Activities)
ampC Beta-lactamase (146 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 352.34 | Molecular Weight (Monoisotopic): 352.0853 | AlogP: -1.58 | #Rotatable Bonds: 5 |
| Polar Surface Area: 128.28 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: -1.94 | CX Basic pKa: 7.39 | CX LogP: -3.11 | CX LogD: -3.39 |
| Aromatic Rings: 0 | Heavy Atoms: 23 | QED Weighted: 0.51 | Np Likeness Score: -0.38 |
References
| 1. (2013) Œ=-lactamase inhibitors, |
Source
Source(1):